Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)
Historic Current Taxes for Entrada Therapeutics (TRDA) over the last 3 years, with Q3 2025 value amounting to $620000.0.
- Entrada Therapeutics' Current Taxes fell 7245.67% to $620000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620000.0, marking a year-over-year decrease of 7245.67%. This contributed to the annual value of $667000.0 for FY2024, which is 8342.45% down from last year.
- According to the latest figures from Q3 2025, Entrada Therapeutics' Current Taxes is $620000.0, which was down 7245.67% from $802000.0 recorded in Q1 2025.
- In the past 5 years, Entrada Therapeutics' Current Taxes ranged from a high of $7.4 million in Q2 2023 and a low of $620000.0 during Q3 2025
- Its 3-year average for Current Taxes is $3.2 million, with a median of $3.1 million in 2023.
- As far as peak fluctuations go, Entrada Therapeutics' Current Taxes tumbled by 4413.64% in 2024, and later tumbled by 8630.23% in 2025.
- Entrada Therapeutics' Current Taxes (Quarter) stood at $4.0 million in 2023, then tumbled by 83.42% to $667000.0 in 2024, then fell by 7.05% to $620000.0 in 2025.
- Its Current Taxes stands at $620000.0 for Q3 2025, versus $802000.0 for Q1 2025 and $667000.0 for Q4 2024.